R Goyal, MM Wassie, JM Winter… - Expert Review of …, 2023 - Taylor & Francis
Background Early detection of pre-cancerous adenomas through screening can reduce colorectal cancer (CRC) incidence. Fecal immunochemical tests are commonly used, but …
K Wisniewska, E Marku, MV Ugurbas… - Healthcare in Low …, 2024 - pagepressjournals.org
The research relevance of cancer diagnostics and treatment is determined by its widespread occurrence and the lack of adequate modern diagnostic methods. The study aims to …
Colonoscopy has been widely regarded as the gold standard for its high diagnostic accuracy and preventive potential. However, its invasive nature, high cost, and suboptimal …
HL Gao, LB Lv, WF Zhao, QW Lu… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND The multi-target stool DNA test (MT-sDNA) has potential utility in the detection of colorectal cancer (CRC), but validation of its clinical accuracy has been limited …
A Caballero-Avendaño, SA Ramírez-García… - Gaceta médica de …, 2023 - scielo.org.mx
El cáncer colorrectal (CCR) es una enfermedad compleja determinada por factores de riesgo genéticos, ambientales y de estilo de vida. Los factores genéticos (hereditarios) …
X Sun, J Fan, W Zhao, Q Lu, J Gu, L Lv, H Gao, G Ye - 2022 - researchsquare.com
Background Multi-target stool DNA (MT-sDNA) test can reduce colorectal cancer (CRC) incidence and mortality as a simple, noninvasive screening method. It is crucial to …